Skip to content
Indigenous, Medical Health Aged Care

First Nations pharmacists awarded inaugural McMillan Grant

Pharmaceutical Society of Australia (PSA) 2 mins read

6 June 2023

The Pharmaceutical Society of Australia (PSA) today proudly announces three recipients of the inaugural PSA Faye McMillan Conference Grant, funding them to attend PSA’s National Conference, PSA23.

Professor Faye McMillan AM is a Wiradjuri yinaa (woman) originally from Trangie, NSW. She is a dedicated community pharmacist and is recognised as the first Indigenous Australian to hold a western degree in pharmacy in this country.

Inspired and supported by Professor McMillan herself, the PSA Faye McMillan Conference Grant will be to be awarded each year to an Aboriginal and/or Torres Strait Islander pharmacist to attend Australia’s leading pharmacist education conference hosted by PSA.

Professor McMillan and PSA are very pleased to announce that this year the grant will support three First Nations pharmacists to attend the PSA23 conference in Sydney from 28-30 July 2023.

The recipients of this year’s grant are -

Alexander Burke (NSW)

Attending this conference will allow me to network with leaders of the profession and to be a role model for young upcoming pharmacists especially those of First Nations background. I believe that the research that I am doing is of vital importance to share with my Australian pharmacy colleagues. My research focuses on how to train pharmacists to be more culturally safe with First Nations patients.

Kirra Natty (NSW)

As an intern I am wanting to broaden my horizons and get as much experience from different conferences and events as I can to see the full scope of pharmacy practice and the possibilities that are available.

Scott Bates (SA)

The PSA conference will be a great way to develop my skills and leadership in Aboriginal Health. Particularly attending the Deadly pharmacist panel. It would be a great opportunity to see what my pharmacy peers have done in this space and share back with the working group my learnings from the panel. Additionally, this could be an incredible resource for networking with likeminded pharmacists.

Quote attributable to PSA National President Dr Fei Sim FPS:

“All health professionals have an obligation to provide culturally safe and appropriate healthcare.”

“PSA acknowledges the ongoing need to increase participation of Aboriginal and Torres Strait Islander people in pharmacy, this grant opportunity represents a genuine commitment by PSA to support the existing pharmacist workforce who identify as Aboriginal and Torres Strait Islander people.”

“Congratulations to each recipient of the PSA Faye McMillian Conference Grant, we look forward to seeing Kirra, Scott and Alexander at PSA23!”

Quotes attributable to Prof. Faye McMillan:

“Creating spaces of belonging is a critical component for reconciliation in this country. Grant opportunities such as this allow us to hold this space for others to come into.”

“Yindyamarra (respect) to all the grant recipients and to PSA, Mandaang guwu (thank you).”

About us:

The Pharmaceutical Society of Australia is the only national peak body that represents all of Australia’s pharmacists across all practice settings. We want every Australian to have access to the best healthcare, and this must include optimising access to pharmacists’ knowledge and medicines expertise at the forefront of our healthcare system.

Contact details:

Georgia Clarke   M: 0480 099 798  E:


More from this category

  • Medical Health Aged Care
  • 18/07/2024
  • 00:00
Dementia Australia

100,000 people worldwide have downloaded BrainTrack – have you?

More than 100,000 people worldwide have downloaded BrainTrack, the multi-award-winning free app supporting people to take a positive step forward in their brain health. Since its release in October 2022 BrainTrack has been downloaded across 202 countries including Australia, India and the United States. BrainTrack, a Dementia Australia initiative, helps people privately monitor and better understand potential changes in their cognition over time through fun, travel-themed games that have been adapted from validated cognitive testing. Users can share their results with their doctor to support the early identification of cognitive changes that may warrant further testing. Dementia Australia ExecutiveDirectorServices,AdvocacyandResearch Dr…

  • Medical Health Aged Care, Science
  • 17/07/2024
  • 14:00
De Motu Cordis

De Motu Cordis (DMC) announces plans for the next stage of development for DMC-IH1, an inhaled epinephrine drug device combination product

Brisbane, QLD – 17 July 2024 – De Motu Cordis (DMC) today announced plans for the next stage of development with its Contract Development and Manufacturing Organization (CDMO) partner, Catalent, at Catalent’s Boston, Morrisville and San Diego sites. These expansion plans encompass services from drug product manufacturing and device assembly through to commercial launch of DMC’s product, DMC-IH1. DMC-IH1 is an inhaled epinephrine drug-device combination product being developed for the treatment of anaphylaxis using a dry powder inhaler (DPI). Catalent DPI drug delivery services offer end-to-end solutions to bring customers through the entire clinical pharma journey by leveraging the commercial…

  • Indigenous, Music
  • 17/07/2024
  • 08:16

Three Generations, Three Songs – a powerful performance set for Australian Festival of Chamber Music

Three Generations, Three Songs – a powerful performance set for Australian Festival of Chamber Music A world first, powerful performance of original songs by…

  • Contains:

Media Outreach made fast, easy, simple.

Feature your press release on Medianet's News Hub every time you distribute with Medianet. Pay per release or save with a subscription.